Výsledky vyhledávání

Akademický článek

Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population

Autor: Sethi S, Make BJ, Robinson SB, Kumar S, Pollack M, Moretz C, Dreyfus J, Xi A, Powell D, Feigler N

Publikováno v: International Journal of COPD, Vol Volume 17, Pp 593-608 (2022)

Sanjay Sethi,1 Barry J Make,2 Scott B Robinson,3 Shambhavi Kumar,3 Michael Pollack,4 Chad Moretz,5 Jill Dreyfus,5 Ann Xi,5 Dakota Powell,5 Norbert Feigler4 1University at Buffalo, Buffalo, NY, USA; 2National Jewish Health, Denver, CO, USA; 3Avalere,

Externí odkaz: https://doaj.org/article/d997ba39f2a24cc88e6209a38008ed2a

Zobrazit plný text záznamu

Akademický článek

Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations

Autor: Fuoco MJ, Mularski RA, Wu B, Moretz C, McBurnie MA, Stanford RH, Crawford P, Gratie D, Salas B

Publikováno v: International Journal of COPD, Vol Volume 16, Pp 2755-2767 (2021)

Morgan Justice Fuoco,1 Richard A Mularski,1 Benjamin Wu,2 Chad Moretz,2 Mary Ann McBurnie,1 Richard H Stanford,2 Phillip Crawford,1 Daniel Gratie,2 Bianca Salas1 1Kaiser Permanente Center for Health Research, Science Programs Department, Portland, OR

Externí odkaz: https://doaj.org/article/529baedac27b4b5eb5025e00eb34690a

Zobrazit plný text záznamu

Akademický článek

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities

Autor: Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B

Publikováno v: International Journal of COPD, Vol Volume 16, Pp 1149-1161 (2021)

Ravi Kalhan,1 David Slade,2 Riju Ray,2 Chad Moretz,3 Guillaume Germain,4 François Laliberté,4 Qin Shen,5 Mei Sheng Duh,6 Sean Dale MacKnight,4 Beth Hahn3 1Asthma and COPD Program, Division of Pulmonary and Critical Care Medicine, Northwestern Unive

Externí odkaz: https://doaj.org/article/5a8c0d9a253545d48c642c2cee9fe241

Zobrazit plný text záznamu

Akademický článek

Incremental Costs Associated with Length of Hospitalization Due to Viral Pneumonia: Impact of Intensive Care and Economic Implications of Reducing the Length of Stay in the Era of COVID-19

Autor: Wu N, Kuznik A, Wang D, Moretz C, Xi A, Kumar S, Hamilton L

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 12, Pp 723-731 (2020)

Ning Wu,1 Andreas Kuznik,1 Degang Wang,1 Chad Moretz,2 Ann Xi,2 Shambhavi Kumar,2 Laurie Hamilton2 1Health Economics and Outcomes Research, Regeneron Pharmaceuticals, Tarrytown, NY, USA; 2Avalere Health, Washington, DC, USACorrespondence: Andreas Kuz

Externí odkaz: https://doaj.org/article/8a4e8265934a43498a3eae59bec052b3

Zobrazit plný text záznamu

Akademický článek

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy

Autor: Moretz C, Hahn B, White J, Goolsby Hunter A, Essoi B, Elliott C, Ray R

Publikováno v: International Journal of COPD, Vol Volume 15, Pp 2715-2725 (2020)

Chad Moretz,1 Beth Hahn,1 John White,2 Alyssa Goolsby Hunter,2 Breanna Essoi,2 Caitlin Elliott,2 Riju Ray3 1US Value Evidence & Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA; 2Optum, Eden Prairie, MN, USA; 3US Medical Affairs, GlaxoSmith

Externí odkaz: https://doaj.org/article/18e481a8ffdf4d19a4f6eac679c670c6

Zobrazit plný text záznamu

Akademický článek

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy

Autor: Moretz C, Cole AL, Mu G, Wu B, Guisinger A, Liu Y, Hahn B, Baylis L

Publikováno v: International Journal of COPD, Vol Volume 15, Pp 2207-2215 (2020)

Chad Moretz,1 Ashley L Cole,2 George Mu,2 Benjamin Wu,1 Amy Guisinger,1 Yunhao Liu,2 Beth Hahn,1 Lee Baylis3 1US Value Evidence & Outcomes, GlaxoSmithKline, Research Triangle Park, Durham, NC, USA; 2VEO Data, Methods, and Analytics, GlaxoSmithKline,

Externí odkaz: https://doaj.org/article/f48917596d494b559866caa0b428a497

Zobrazit plný text záznamu

Akademický článek

Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol

Autor: Moretz C, Bengtson LGS, Sharpsten L, Koep E, Le L, Tong J, Stanford RH, Hahn B, Ray R

Publikováno v: International Journal of COPD, Vol Volume 14, Pp 2047-2060 (2019)

Chad Moretz1, Lindsay GS Bengtson2, Lucie Sharpsten2, Eleena Koep2, Lisa Le2, Junliang Tong2, Richard H Stanford1, Beth Hahn1, Riju Ray1 1Glaxo Smith Kline, Research Triangle Park, Durham, NC, USA; 2Optum, Eden Prairie, MN, USACorrespondence: Chad Mo

Externí odkaz: https://doaj.org/article/22c75b6b9439405e82cfc0f4e4adda79

Zobrazit plný text záznamu

Akademický článek

Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study

Autor: Moretz C, Sharpsten L, Bengtson LGS, Koep E, Le L, Tong J, Stanford RH, Hahn B, Ray R

Publikováno v: International Journal of COPD, Vol Volume 14, Pp 1721-1737 (2019)

Chad Moretz,1 Lucie Sharpsten,2 Lindsay GS Bengtson,2 Eleena Koep,2 Lisa Le,2 Junliang Tong,2 Richard H Stanford,1 Beth Hahn,1 Riju Ray31US Value Evidence and Outcomes, GSK, Durham, NC, USA; 2Health Economics and Outcomes Research, Optum, Eden Prairi

Externí odkaz: https://doaj.org/article/a3a09df61f7e4d34997cce4d5b160f21

Zobrazit plný text záznamu

Akademický článek

Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD

Autor: Moretz C, Annavarapu S, Luthra R, Goldfarb S, Renda A, Shaikh A, Kaila S

Publikováno v: International Journal of COPD, Vol Volume 14, Pp 439-446 (2019)

Chad Moretz,1 Srinivas Annavarapu,1 Rakesh Luthra,2 Seth Goldfarb,1 Andrew Renda,3 Asif Shaikh,2 Shuchita Kaila2 1Comprehensive Health Insights, Louisville, KY, USA; 2Boehringer Ingelheim, Ridgefield, CT, USA; 3Humana Inc., Louisville, KY, USA Backgr

Externí odkaz: https://doaj.org/article/2d44e23b8a3143868c90b6f856dff25f

Zobrazit plný text záznamu

Akademický článek

Development and validation of a predictive model to identify patients at risk of severe COPD exacerbations using administrative claims data

Autor: Annavarapu S, Goldfarb S, Gelb M, Moretz C, Renda A, Kaila S

Publikováno v: International Journal of COPD, Vol Volume 13, Pp 2121-2130 (2018)

Srinivas Annavarapu,1 Seth Goldfarb,1 Melissa Gelb,2 Chad Moretz,1 Andrew Renda,3 Shuchita Kaila2 1Comprehensive Health Insights, Louisville, KY, 2Boehringer Ingelheim, Ridgefield, CT, 3Humana, Louisville, KY, USA Background: Patients with COPD often

Externí odkaz: https://doaj.org/article/06d4bc459ab040ceb47b49a656b0a1b4

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání